These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6784907

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Finklestein JZ, Shore N, Krivit W, Hammond D, Higgins G.
    Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of phase I and II chemotherapeutic agents against human lymphomas heterotransplanted in nude mice.
    Sordillo PP, Helson C, Lesser M, Helson L.
    Oncology; 1983 Nov; 40(1):15-7. PubMed ID: 6823403
    [Abstract] [Full Text] [Related]

  • 30. Phase II study of dianhydrogalactitol in malignant glioma.
    Espana P, Wiernik PH, Walker MD.
    Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Haas CD, Lehane D, Bottomley R.
    Med Pediatr Oncol; 1983 Aug; 11(4):281-3. PubMed ID: 6888328
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical observation of 15 cases of chronic myelogenous leukemia treated with 1,2,5,6-dianhydrodulcitol].
    Huang ZG.
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):356-8. PubMed ID: 6957285
    [No Abstract] [Full Text] [Related]

  • 36. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBD.
    Horváth IP, Csetényi J, Kerpel-Fronius S, Hindy I, Eckhardt S.
    Eur J Cancer (1965); 1979 Mar; 15(3):337-44. PubMed ID: 446515
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS, Lui V, Trueworthy R, van Eys J.
    Cancer Treat Rep; 1981 Mar; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.